{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:08:48Z","timestamp":1791889728520,"version":"4.3.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00228-020-03039-z","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T07:03:45Z","timestamp":1610003025000},"page":"1019-1028","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Maternal paracetamol intake and fetal ductus arteriosus constriction\/closure: comprehensive signal evaluation using the Austin Bradford Hill criteria"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3365-1374","authenticated-orcid":false,"given":"Manfred","family":"Hauben","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Lobello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Tressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent P.","family":"Zucal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"3039_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/npm-15814031","volume":"8","author":"F Genovese","year":"2015","unstructured":"Genovese F, Marilli I, Benintende G, Privitera A, Gulino FA, Iozza I, Cimino C, Palumbo MA (2015) Diagnosis and management of fetal ductus arteriosus constriction-closure. J Neonatal Perinatal Med 8:57\u201362. https:\/\/doi.org\/10.3233\/npm-15814031","journal-title":"J Neonatal Perinatal Med"},{"key":"3039_CR2","unstructured":"Martinez R (2002) Premature closure of the ductus arteriosus. https:\/\/sonoworld.com\/TheFetus\/page.aspx?id=1071. Accessed January 17, 2020"},{"key":"3039_CR3","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/eurheartj\/ehp128","volume":"30","author":"M Gewillig","year":"2009","unstructured":"Gewillig M, Brown SC, De Catte L, Debeer A, Eyskens B, Cossey V, Van Schoubroeck D, Van Hole C, Devlieger R (2009) Premature foetal closure of the arterial duct: clinical presentations and outcome. Eur Heart J 30:1530\u20131536. https:\/\/doi.org\/10.1093\/eurheartj\/ehp128","journal-title":"Eur Heart J"},{"key":"3039_CR4","first-page":"1","volume":"5","author":"S Mehta","year":"2003","unstructured":"Mehta S, Younoszai A, Pietz J, Achanti B (2003) Pharmacological closure of the patent ductus arteriosus. Images Paediatr Cardiol 5:1\u201315","journal-title":"Images Paediatr Cardiol"},{"key":"3039_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3109\/14767058.2015.1029912","volume":"29","author":"A Memisoglu","year":"2016","unstructured":"Memisoglu A, Alp Unkar Z, Cetiner N, Akalin F, Ozdemir H, Bilgen HS, Ozek E (2016) Ductal closure with intravenous paracetamol: a new approach to patent ductus arteriosus treatment. J Matern Fetal Neonatal Med 29:987\u2013990. https:\/\/doi.org\/10.3109\/14767058.2015.1029912","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3039_CR6","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jama.2018.1896","volume":"319","author":"S Mitra","year":"2018","unstructured":"Mitra S, Florez ID, Tamayo ME, Mbuagbaw L, Vanniyasingam T, Veroniki AA, Zea AM, Zhang Y, Sadeghirad B, Thabane L (2018) Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. JAMA 319:1221\u20131238. https:\/\/doi.org\/10.1001\/jama.2018.1896","journal-title":"JAMA"},{"key":"3039_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/apa.14137","volume":"107","author":"S Juujarvi","year":"2018","unstructured":"Juujarvi S, Saarela T, Hallman M, Aikio O (2018) Intravenous paracetamol was associated with closure of the ductus arteriosus in extremely premature infants. Acta Paediatr 107:605\u2013610. https:\/\/doi.org\/10.1111\/apa.14137","journal-title":"Acta Paediatr"},{"key":"3039_CR8","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00431-016-2731-9","volume":"175","author":"E Valerio","year":"2016","unstructured":"Valerio E, Valente MR, Salvadori S, Frigo AC, Baraldi E, Lago P (2016) Intravenous paracetamol for PDA closure in the preterm: a single-center experience. Eur J Pediatr 175:953\u2013966. https:\/\/doi.org\/10.1007\/s00431-016-2731-9","journal-title":"Eur J Pediatr"},{"key":"3039_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/1060028014557564","volume":"49","author":"J Le","year":"2015","unstructured":"Le J, Gales MA, Gales BJ (2015) Acetaminophen for patent ductus arteriosus. Ann Pharmacother 49:241\u2013246. https:\/\/doi.org\/10.1177\/1060028014557564","journal-title":"Ann Pharmacother"},{"key":"3039_CR10","doi-asserted-by":"publisher","unstructured":"EL-Khuffash A, James AT, Cleary A, Semberova J, Franklin O, Miletin J (2015) Late medical therapy of patent ductus arteriosus using intravenous paracetamol. Arch Dis Child Fetal Neonatal Ed 100:F253\u2013F256. https:\/\/doi.org\/10.1136\/archdischild-2014-307930","DOI":"10.1136\/archdischild-2014-307930"},{"key":"3039_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000345337","volume":"103","author":"MY Oncel","year":"2013","unstructured":"Oncel MY, Yurttutan S, Degirmencioglu H, Uras N, Altug N, Erdeve O, Dilmen U (2013) Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology 103:166\u2013169. https:\/\/doi.org\/10.1159\/000345337","journal-title":"Neonatology"},{"key":"3039_CR12","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.3109\/14767058.2013.871630","volume":"27","author":"I Kessel","year":"2014","unstructured":"Kessel I, Waisman D, Lavie-Nevo K, Golzman M, Lorber A, Rotschild A (2014) Paracetamol effectiveness, safety and blood level monitoring during patent ductus arteriosus closure: a case series. J Matern Fetal Neonatal Med 27:1719\u20131721. https:\/\/doi.org\/10.3109\/14767058.2013.871630","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3039_CR13","doi-asserted-by":"publisher","first-page":"e1618","DOI":"10.1542\/peds.2011-0359","volume":"128","author":"C Hammerman","year":"2011","unstructured":"Hammerman C, Bin-Nun A, Markovitch E, Schimmel MS, Kaplan M, Fink D (2011) Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 128:e1618\u2013e1621. https:\/\/doi.org\/10.1542\/peds.2011-0359","journal-title":"Pediatrics"},{"key":"3039_CR14","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.7863\/jum.2012.31.8.1285","volume":"31","author":"C Enzensberger","year":"2012","unstructured":"Enzensberger C, Wienhard J, Weichert J, Kawecki A, Degenhardt J, Vogel M, Axt-Fliedner R (2012) Idiopathic constriction of the fetal ductus arteriosus: three cases and review of the literature. J Ultrasound Med 31:1285\u20131291. https:\/\/doi.org\/10.7863\/jum.2012.31.8.1285","journal-title":"J Ultrasound Med"},{"key":"3039_CR15","doi-asserted-by":"publisher","first-page":"774","DOI":"10.4070\/kcj.2013.43.11.774","volume":"43","author":"EY Choi","year":"2013","unstructured":"Choi EY, Li M, Choi CW, Park KH, Choi JY (2013) A case of progressive ductal constriction in a fetus. Korean Circ J 43:774\u2013781. https:\/\/doi.org\/10.4070\/kcj.2013.43.11.774","journal-title":"Korean Circ J"},{"key":"3039_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/bcp.13778","volume":"85","author":"K Allegaert","year":"2019","unstructured":"Allegaert K, Mian P, Lapillonne A, van den Anker JN (2019) Maternal paracetamol intake and fetal ductus arteriosus constriction or closure: a case series analysis. Br J Clin Pharmacol 85:245\u2013251. https:\/\/doi.org\/10.1111\/bcp.13778","journal-title":"Br J Clin Pharmacol"},{"key":"3039_CR17","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3109\/14767058.2015.1015413","volume":"29","author":"LM Lopes","year":"2016","unstructured":"Lopes LM, Carrilho MC, Francisco RP, Lopes MA, Krebs VL, Zugaib M (2016) Fetal ductus arteriosus constriction and closure: analysis of the causes and perinatal outcome related to 45 consecutive cases. J Matern Fetal Neonatal Med 29:638\u2013645. https:\/\/doi.org\/10.3109\/14767058.2015.1015413","journal-title":"J Matern Fetal Neonatal Med"},{"key":"3039_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0028-2243(90)90171-v","volume":"35","author":"E Demandt","year":"1990","unstructured":"Demandt E, Legius E, Devlieger H, Lemmens F, Proesmans W, Eggermont E (1990) Prenatal indomethacin toxicity in one member of monozygous twins; a case report. Eur J Obstet Gynecol Reprod Biol 35:267\u2013269. https:\/\/doi.org\/10.1016\/0028-2243(90)90171-v","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3039_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/s0002-9378(97)70184-4","volume":"177","author":"ST Vermillion","year":"1997","unstructured":"Vermillion ST, Scardo JA, Lashus AG, Wiles HB (1997) The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age. Am J Obstet Gynecol 177:256\u2013259; discussion 259-261. https:\/\/doi.org\/10.1016\/s0002-9378(97)70184-4","journal-title":"Am J Obstet Gynecol"},{"key":"3039_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/uog.1038","volume":"23","author":"M Auer","year":"2004","unstructured":"Auer M, Brezinka C, Eller P, Luze K, Schweigmann U, Schwarzler P (2004) Prenatal diagnosis of intrauterine premature closure of the ductus arteriosus following maternal diclofenac application. Ultrasound Obstet Gynecol 23:513\u2013516. https:\/\/doi.org\/10.1002\/uog.1038","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3039_CR21","doi-asserted-by":"publisher","unstructured":"Aker K, Brantberg A, Nyrnes SA (2015) Prenatal constriction of the ductus arteriosus following maternal diclofenac medication in the third trimester. BMJ Case Rep 2015:bcr2015210473. https:\/\/doi.org\/10.1136\/bcr-2015-210473","DOI":"10.1136\/bcr-2015-210473"},{"key":"3039_CR22","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3850","volume":"141","author":"IAM Schierz","year":"2018","unstructured":"Schierz IAM, Giuffre M, Piro E, La Placa S, Corsello G (2018) A case of cardiomyopathy due to premature ductus arteriosus closure: the Flip side of paracetamol. Pediatrics 141:e20163850. https:\/\/doi.org\/10.1542\/peds.2016-3850","journal-title":"Pediatrics"},{"key":"3039_CR23","unstructured":"(2018) RCOG review clarifies pain relief options for women during pregnancy and breastfeeding. https:\/\/www.rcog.org.uk\/en\/news\/new-rcog-review-clarifies-pain-relief-options-for-women-during-pregnancy-and-breastfeeding\/. Accessed January 17, 2020"},{"key":"3039_CR24","doi-asserted-by":"crossref","unstructured":"McCullough M (2011) Dental notes. Analgesics and pain relief in pregnancy and breastfeeding. Aust Prescr 34:10","DOI":"10.18773\/austprescr.2011.008"},{"key":"3039_CR25","first-page":"1004","volume":"1","author":"K Toda","year":"2018","unstructured":"Toda K (2018) Acetaminophen is not safe in pregnancy. Ann Pregnancy Birth 1:1004","journal-title":"Ann Pregnancy Birth"},{"key":"3039_CR26","doi-asserted-by":"publisher","first-page":"6098","DOI":"10.2174\/1381612823666170825123754","volume":"23","author":"HR Price","year":"2017","unstructured":"Price HR, Collier AC (2017) Analgesics in pregnancy: an update on use, safety and pharmacokinetic changes in drug disposition. Curr Pharm Des 23:6098\u20136114. https:\/\/doi.org\/10.2174\/1381612823666170825123754","journal-title":"Curr Pharm Des"},{"issue":"25","key":"3039_CR27","first-page":"27","volume":"56","author":"M Babb","year":"2010","unstructured":"Babb M, Koren G, Einarson A (2010) Treating pain during pregnancy. Can Fam Physician 56(25):27","journal-title":"Can Fam Physician"},{"key":"3039_CR28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12884-017-1399-0","volume":"17","author":"GE Harris","year":"2017","unstructured":"Harris GE, Wood M, Eberhard-Gran M, Lundqvist C, Nordeng H (2017) Patterns and predictors of analgesic use in pregnancy: a longitudinal drug utilization study with special focus on women with migraine. BMC Pregnancy Childbirth 17:224. https:\/\/doi.org\/10.1186\/s12884-017-1399-0","journal-title":"BMC Pregnancy Childbirth"},{"key":"3039_CR29","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/uog.6453","volume":"34","author":"S Sridharan","year":"2009","unstructured":"Sridharan S, Archer N, Manning N (2009) Premature constriction of the fetal ductus arteriosus following the maternal consumption of camomile herbal tea. Ultrasound Obstet Gynecol 34:358\u2013359. https:\/\/doi.org\/10.1002\/uog.6453","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3039_CR30","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/jp.2011.153","volume":"32","author":"P Zielinsky","year":"2012","unstructured":"Zielinsky P, Piccoli AL Jr, Manica JL, Nicoloso LH, Vian I, Bender L, Pizzato P, Pizzato M, Swarowsky F, Barbisan C, Mello A, Garcia SC (2012) Reversal of fetal ductal constriction after maternal restriction of polyphenol-rich foods: an open clinical trial. J Perinatol 32:574\u2013579. https:\/\/doi.org\/10.1038\/jp.2011.153","journal-title":"J Perinatol"},{"key":"3039_CR31","unstructured":"(2019) Pharmacovigilance Risk Assessment Committee (PRAC) Minutes of the meeting on 12\u201315 March 2019. https:\/\/www.ema.europa.eu\/en\/documents\/minutes\/minutes-prac-meeting-12-15-march-2019_en.pdf. Accessed February 4, 2020"},{"key":"3039_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13256-018-1580-8","volume":"12","author":"N Belai","year":"2018","unstructured":"Belai N, Gebrehiwet S, Fitsum Y, Russom M (2018) Hydrochlorothiazide and risk of hearing disorder: a case series. J Med Case Rep 12:135. https:\/\/doi.org\/10.1186\/s13256-018-1580-8","journal-title":"J Med Case Rep"},{"key":"3039_CR33","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/archoto.2010.111","volume":"136","author":"TM Davidson","year":"2010","unstructured":"Davidson TM, Smith WM (2010) The Bradford Hill criteria and zinc-induced anosmia: a causality analysis. Arch Otolaryngol Head Neck Surg 136:673\u2013676. https:\/\/doi.org\/10.1001\/archoto.2010.111","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"3039_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12325-018-0665-5","volume":"35","author":"CS Muganurmath","year":"2018","unstructured":"Muganurmath CS, Curry AL, Schindzielorz AH (2018) Causality assessment of olfactory and gustatory dysfunction associated with intranasal fluticasone propionate: application of the Bradford Hill criteria. Adv Ther 35:173\u2013190. https:\/\/doi.org\/10.1007\/s12325-018-0665-5","journal-title":"Adv Ther"},{"key":"3039_CR35","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2165\/00002018-200730040-00006","volume":"30","author":"M Perrio","year":"2007","unstructured":"Perrio M, Voss S, Shakir SA (2007) Application of the Bradford Hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance. Drug Saf 30:333\u2013346. https:\/\/doi.org\/10.2165\/00002018-200730040-00006","journal-title":"Drug Saf"},{"key":"3039_CR36","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2165\/00002018-200225060-00012","volume":"25","author":"SA Shakir","year":"2002","unstructured":"Shakir SA, Layton D (2002) Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria. Drug Saf 25:467\u2013471. https:\/\/doi.org\/10.2165\/00002018-200225060-00012","journal-title":"Drug Saf"},{"key":"3039_CR37","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","volume":"374","author":"SA Rasmussen","year":"2016","unstructured":"Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR (2016) Zika virus and birth defects--reviewing the evidence for causality. N Engl J Med 374:1981\u20131987. https:\/\/doi.org\/10.1056\/NEJMsr1604338","journal-title":"N Engl J Med"},{"key":"3039_CR38","doi-asserted-by":"publisher","unstructured":"Frank C, Faber M, Stark K (2016) Causal or not: applying the Bradford Hill aspects of evidence to the association between Zika virus and microcephaly. EMBO Mol Med 8:305-307. https:\/\/doi.org\/10.15252\/emmm.201506058","DOI":"10.15252\/emmm.201506058"},{"key":"3039_CR39","doi-asserted-by":"publisher","unstructured":"Williamson J (2018) Establishing the teratogenicity of Zika and evaluating causal criteria. Synthese. https:\/\/doi.org\/10.1007\/s11229-018-1866-9","DOI":"10.1007\/s11229-018-1866-9"},{"key":"3039_CR40","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1002\/pds.5016","volume":"29","author":"MM Beex-Oosterhuis","year":"2020","unstructured":"Beex-Oosterhuis MM, Samb A, Heerdink ER, Souverein PC, Van Gool AR, Meyboom RHB, van Marum RJ (2020) Safety of clozapine use during pregnancy: analysis of international pharmacovigilance data. Pharmacoepidemiol Drug Saf 29:725\u2013735. https:\/\/doi.org\/10.1002\/pds.5016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3039_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.drudis.2008.12.012","volume":"14","author":"M Hauben","year":"2009","unstructured":"Hauben M, Bate A (2009) Decision support methods for the detection of adverse events in post-marketing data. Drug Discov Today 14:343\u2013357. https:\/\/doi.org\/10.1016\/j.drudis.2008.12.012","journal-title":"Drug Discov Today"},{"key":"3039_CR42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2165\/00002018-200932020-00003","volume":"32","author":"M Hauben","year":"2009","unstructured":"Hauben M, Aronson JK (2009) Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions. Drug Saf 32:99\u2013110. https:\/\/doi.org\/10.2165\/00002018-200932020-00003","journal-title":"Drug Saf"},{"key":"3039_CR43","volume-title":"Reproductive health indicators: guidelines for their generation, interpretation and analysis for global monitoring","author":"World Health Organization","year":"2006","unstructured":"World Health Organization (2006) Reproductive health indicators: guidelines for their generation, interpretation and analysis for global monitoring. World Health Organization, Geneva, Switzerland"},{"key":"3039_CR44","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/clpt.2013.24","volume":"93","author":"R Harpaz","year":"2013","unstructured":"Harpaz R, DuMouchel W, LePendu P, Bauer-Mehren A, Ryan P, Shah NH (2013) Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system. Clin Pharmacol Ther 93:539\u2013546. https:\/\/doi.org\/10.1038\/clpt.2013.24","journal-title":"Clin Pharmacol Ther"},{"key":"3039_CR45","unstructured":"(2012) Online Help for Empirica\u2122 Signal. Release 7.3.3.0.354. Oracle USA, Inc, Redwood City, CA"},{"key":"3039_CR46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/8756479315598524","volume":"31","author":"TA Lynch","year":"2015","unstructured":"Lynch TA, Abel DE (2015) Teratogens and congenital heart disease. J Diagn Med Sonogr 31:301\u2013305","journal-title":"J Diagn Med Sonogr"},{"key":"3039_CR47","unstructured":"(2018) Pharmacovigilance Risk Assessment Committee (PRAC) Minutes of the meeting on the meeting on 29\u201331 October 2018. https:\/\/www.ema.europa.eu\/en\/documents\/minutes\/minutes-prac-meeting-29-31-october-2018_en.pdf. Accessed January 17, 2020"},{"key":"3039_CR48","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/med.0000000000000338","volume":"24","author":"P Hurtado-Gonzalez","year":"2017","unstructured":"Hurtado-Gonzalez P, Mitchell RT (2017) Analgesic use in pregnancy and male reproductive development. Curr Opin Endocrinol Diabetes Obes 24:225\u2013232. https:\/\/doi.org\/10.1097\/med.0000000000000338","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"3039_CR49","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/0090-6980(84)90241-7","volume":"28","author":"K Momma","year":"1984","unstructured":"Momma K, Hagiwara H, Konishi T (1984) Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs:study of additional 34 drugs. Prostaglandins 28:527\u2013536. https:\/\/doi.org\/10.1016\/0090-6980(84)90241-7","journal-title":"Prostaglandins"},{"key":"3039_CR50","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/0002-9378(90)90042-6","volume":"162","author":"K Momma","year":"1990","unstructured":"Momma K, Takao A (1990) Transplacental cardiovascular effects of four popular analgesics in rats. Am J Obstet Gynecol 162:1304\u20131310. https:\/\/doi.org\/10.1016\/0002-9378(90)90042-6","journal-title":"Am J Obstet Gynecol"},{"key":"3039_CR51","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/adc.2010.204552","volume":"96","author":"K Allegaert","year":"2011","unstructured":"Allegaert K, Palmer GM, Anderson BJ (2011) The pharmacokinetics of intravenous paracetamol in neonates: size matters most. Arch Dis Child 96:575\u2013580. https:\/\/doi.org\/10.1136\/adc.2010.204552","journal-title":"Arch Dis Child"},{"key":"3039_CR52","first-page":"182","volume":"87","author":"MA Naga Rani","year":"1989","unstructured":"Naga Rani MA, Joseph T, Narayanan R (1989) Placental transfer of paracetamol. J Indian Med Assoc 87:182\u2013183","journal-title":"J Indian Med Assoc"},{"key":"3039_CR53","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1055\/s-0036-1593845","volume":"34","author":"JF Nitsche","year":"2017","unstructured":"Nitsche JF, Patil AS, Langman LJ, Penn HJ, Derleth D, Watson WJ, Brost BC (2017) Transplacental passage of acetaminophen in term pregnancy. Am J Perinatol 34:541\u2013543. https:\/\/doi.org\/10.1055\/s-0036-1593845","journal-title":"Am J Perinatol"},{"key":"3039_CR54","unstructured":"(1995) Guidelines for Preparing Core Clinical-Safety Information on Drugs \u2013 Report of CIOMS Working Group III. Council for International Organizations of Medical Sciences, Geneva, Switzerland"},{"key":"3039_CR55","unstructured":"Veneziano M, Romeo C, Verdi F, Braghetto M, Crepaz R, Messini S (2009) Premature constriction of fetal ductus arteriosus after maternal assumption of acetaminophen (paracetamol): report of two cases. Idiopathic or drug induced? J Perinat Med 37:794"},{"key":"3039_CR56","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1007\/s00467-003-1338-3","volume":"19","author":"D Benini","year":"2004","unstructured":"Benini D, Fanos V, Cuzzolin L, Tato L (2004) In utero exposure to nonsteroidal anti-inflammatory drugs: neonatal renal failure. Pediatr Nephrol 19:232\u2013234. https:\/\/doi.org\/10.1007\/s00467-003-1338-3","journal-title":"Pediatr Nephrol"},{"key":"3039_CR57","doi-asserted-by":"publisher","unstructured":"Villamizar-Duran R, Mosquera W, Gutierrez J, Mena J, Guzman G (2017) La hipertensi\u00f3n pulmonar en el reci\u00e9n nacido con cierre del ductus arterioso en el \u00fatero y secuencia de la perfusi\u00f3n arterial reversa en el embarazo gemelar [Pulmonary hypertension of the newborn with in utero closure of the ductus arteriosus and twin reversed arterial perfusion sequence]. Rev Colomb Cardiol 24:410.e411-410.e416. https:\/\/doi.org\/10.1016\/j.rccar.2016.11.007","DOI":"10.1016\/j.rccar.2016.11.007"},{"key":"3039_CR58","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/00015385.2017.1314876","volume":"72","author":"M Gewillig","year":"2017","unstructured":"Gewillig M, Brown SC, Roggen M, Eyskens B, Heying R, Givron P, Cools B, de Catte L (2017) Dysfunction of the foetal arterial duct results in a wide spectrum of cardiovascular pathology. Acta Cardiol 72:625\u2013635. https:\/\/doi.org\/10.1080\/00015385.2017.1314876","journal-title":"Acta Cardiol"},{"key":"3039_CR59","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s00246-008-9269-1","volume":"30","author":"SI Nygaard","year":"2009","unstructured":"Nygaard SI, Petersen OB, Garne E, Sorensen KE (2009) Spontaneous prenatal ductal closure: postnatal diagnosis? Pediatr Cardiol 30:176\u2013180. https:\/\/doi.org\/10.1007\/s00246-008-9269-1","journal-title":"Pediatr Cardiol"},{"key":"3039_CR60","doi-asserted-by":"publisher","first-page":"H572","DOI":"10.1152\/ajpheart.00822.2015","volume":"311","author":"CW Hooper","year":"2016","unstructured":"Hooper CW, Delaney C, Streeter T, Yarboro MT, Poole S, Brown N, Slaughter JC, Cotton RB, Reese J, Shelton EL (2016) Selective serotonin reuptake inhibitor exposure constricts the mouse ductus arteriosus in utero. Am J Physiol Heart Circ Physiol 311:H572\u2013H581. https:\/\/doi.org\/10.1152\/ajpheart.00822.2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3039_CR61","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1111\/1471-0528.15872","volume":"126","author":"K Dathe","year":"2019","unstructured":"Dathe K, Frank J, Padberg S, Hultzsch S, Meixner K, Beck E, Meister R, Schaefer C (2019) Negligible risk of prenatal ductus arteriosus closure or fetal renal impairment after third-trimester paracetamol use: evaluation of the German Embryotox cohort. BJOG 126:1560\u20131567. https:\/\/doi.org\/10.1111\/1471-0528.15872","journal-title":"BJOG"},{"key":"3039_CR62","doi-asserted-by":"publisher","first-page":"138","DOI":"10.5863\/1551-6776-12.3.138","volume":"12","author":"JE Dice","year":"2007","unstructured":"Dice JE, Bhatia J (2007) Patent ductus arteriosus: an overview. J Pediatr Pharmacol Ther 12:138\u2013146. https:\/\/doi.org\/10.5863\/1551-6776-12.3.138","journal-title":"J Pediatr Pharmacol Ther"},{"key":"3039_CR63","first-page":"42","volume":"24","author":"E Pistulli","year":"2014","unstructured":"Pistulli E, Hamiti A, Buba S, Hoxha A, Kelmendi N, Vyshka G (2014) The association between patent ductus arteriosus and perinatal infection in a group of low birth weight preterm infants. Iran J Pediatr 24:42\u201348","journal-title":"Iran J Pediatr"},{"key":"3039_CR64","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/s0022-3476(96)70356-6","volume":"128","author":"A Gonzalez","year":"1996","unstructured":"Gonzalez A, Sosenko IR, Chandar J, Hummler H, Claure N, Bancalari E (1996) Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less. J Pediatr 128:470\u2013478. https:\/\/doi.org\/10.1016\/s0022-3476(96)70356-6","journal-title":"J Pediatr"},{"key":"3039_CR65","doi-asserted-by":"publisher","first-page":"197","DOI":"10.4314\/ejhs.v27i2.13","volume":"27","author":"D Mekonnen","year":"2017","unstructured":"Mekonnen D (2017) Clinically confirmed congenital rubella syndrome: the role of echocardiography. Ethiop J Health Sci 27:197\u2013202. https:\/\/doi.org\/10.4314\/ejhs.v27i2.13","journal-title":"Ethiop J Health Sci"},{"key":"3039_CR66","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/uog.882","volume":"22","author":"F Vinals","year":"2003","unstructured":"Vinals F, Heredia F, Giuliano A (2003) The role of the three vessels and trachea view (3VT) in the diagnosis of congenital heart defects. Ultrasound Obstet Gynecol 22:358\u2013367. https:\/\/doi.org\/10.1002\/uog.882","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3039_CR67","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.siny.2013.01.007","volume":"18","author":"H Gardiner","year":"2013","unstructured":"Gardiner H, Chaoui R (2013) The fetal three-vessel and tracheal view revisited. Semin Fetal Neonatal Med 18:261\u2013268. https:\/\/doi.org\/10.1016\/j.siny.2013.01.007","journal-title":"Semin Fetal Neonatal Med"},{"key":"3039_CR68","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/j.2205-0140.2013.tb00243.x","volume":"16","author":"R Mogra","year":"2013","unstructured":"Mogra R (2013) Simplifying ultrasound assessment of the fetal heart: incorporating the complete three vessel view into routine screening. Australas J Ultrasound Med 16:168\u2013175. https:\/\/doi.org\/10.1002\/j.2205-0140.2013.tb00243.x","journal-title":"Australas J Ultrasound Med"},{"key":"3039_CR69","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3892\/etm.2018.6943","volume":"17","author":"Z Gou","year":"2019","unstructured":"Gou Z, Zhang J, Yan X, Wang Z, Li S, Deng X (2019) Variations in ductus arteriosus Doppler parameters in different sonographic views during the second half of gestation. Exp Ther Med 17:502\u2013506. https:\/\/doi.org\/10.3892\/etm.2018.6943","journal-title":"Exp Ther Med"},{"key":"3039_CR70","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1556\/2006.5.2016.001","volume":"5","author":"KE Gendreau","year":"2016","unstructured":"Gendreau KE, Potenza MN (2016) Publicity and reports of behavioral addictions associated with dopamine agonists. J Behav Addict 5:140\u2013143. https:\/\/doi.org\/10.1556\/2006.5.2016.001","journal-title":"J Behav Addict"},{"key":"3039_CR71","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/pds.3529","volume":"23","author":"F Maignen","year":"2014","unstructured":"Maignen F, Hauben M, Hung E, Van Holle L, Dogne JM (2014) Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases. Pharmacoepidemiol Drug Saf 23:195\u2013207. https:\/\/doi.org\/10.1002\/pds.3529","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3039_CR72","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s40264-013-0063-5","volume":"36","author":"F Salvo","year":"2013","unstructured":"Salvo F, Leborgne F, Thiessard F, Moore N, Begaud B, Pariente A (2013) A potential event-competition bias in safety signal detection: results from a spontaneous reporting research database in France. Drug Saf 36:565\u2013572. https:\/\/doi.org\/10.1007\/s40264-013-0063-5","journal-title":"Drug Saf"},{"key":"3039_CR73","doi-asserted-by":"publisher","first-page":"551","DOI":"10.2165\/00002018-200730060-00009","volume":"30","author":"M Hauben","year":"2007","unstructured":"Hauben M, Reich L, DeMicco J, Kim K (2007) 'Extreme duplication' in the US FDA adverse events reporting system database. Drug Saf 30:551\u2013554. https:\/\/doi.org\/10.2165\/00002018-200730060-00009","journal-title":"Drug Saf"},{"key":"3039_CR74","unstructured":"Helliker K (2015) Pregnant women get more ultrasounds, without clear medical need. https:\/\/www.wsj.com\/articles\/pregnant-women-get-more-ultrasounds-without-clear-medical-need-1437141219."},{"key":"3039_CR75","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025482","volume":"9","author":"C Ferrier","year":"2019","unstructured":"Ferrier C, Dhombres F, Khoshnood B, Randrianaivo H, Perthus I, Guilbaut L, Durand-Zaleski I, Jouannic JM (2019) Trends in resource use and effectiveness of ultrasound detection of fetal structural anomalies in France: a multiple registry-based study. BMJ Open 9:e025482. https:\/\/doi.org\/10.1136\/bmjopen-2018-025482","journal-title":"BMJ Open"},{"key":"3039_CR76","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ebiom.2017.10.023","volume":"26","author":"L Bremer","year":"2017","unstructured":"Bremer L, Goletzke J, Wiessner C, Pagenkemper M, Gehbauer C, Becher H, Tolosa E, Hecher K, Arck PC, Diemert A, Tiegs G (2017) Paracetamol medication during pregnancy: insights on intake frequencies, dosages and effects on hematopoietic stem cell populations in cord blood from a longitudinal prospective pregnancy cohort. EBioMedicine 26:146\u2013151. https:\/\/doi.org\/10.1016\/j.ebiom.2017.10.023","journal-title":"EBioMedicine"},{"key":"3039_CR77","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/nejm197703032960904","volume":"296","author":"H Jick","year":"1977","unstructured":"Jick H (1977) The discovery of drug-induced illness. N Engl J Med 296:481\u2013485. https:\/\/doi.org\/10.1056\/nejm197703032960904","journal-title":"N Engl J Med"},{"key":"3039_CR78","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1046\/j.1365-2125.2003.01847.x","volume":"55","author":"M Pirmohamed","year":"2003","unstructured":"Pirmohamed M, Park BK (2003) Adverse drug reactions: back to the future. Br J Clin Pharmacol 55:486\u2013492. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.01847.x","journal-title":"Br J Clin Pharmacol"},{"issue":"405\u2013410","key":"3039_CR79","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1590\/s0066-782x2003001200007","volume":"81","author":"S Luchese","year":"2003","unstructured":"Luchese S, M\u00e2nica JL, Zielinsky P (2003) Intrauterine ductus arteriosus constriction: analysis of a historic cohort of 20 cases. Arq Bras Cardiol 81(405\u2013410):399\u2013404. https:\/\/doi.org\/10.1590\/s0066-782x2003001200007","journal-title":"Arq Bras Cardiol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-03039-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-020-03039-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-020-03039-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T12:15:03Z","timestamp":1623068103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-020-03039-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":79,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["3039"],"URL":"https:\/\/doi.org\/10.1007\/s00228-020-03039-z","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"30 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Manfred Hauben, MD, MPH, is a full-time employee of Pfizer Inc. and owns stocks and stock options in Pfizer and stocks in other pharmaceutical companies that may manufacture and\/or market drugs mentioned in this article.Stephen Bai, PhD, is a clinical pharmacology consultant for Pfizer Inc. He is employed by Atrium Staffing, a company Pfizer contracts with for staffing needs.Eric Hung, PharmD, is a full-time employee of Pfizer Inc. and owns stocks and stock options in Pfizer.Kasia Lobello, MD, is a full-time employee of Pfizer Inc. and owns stocks and stock options in Pfizer.Charles Tressler, MD, was a full-time employee of Pfizer Inc. at the time that this study was conducted and owned stocks and stock options in Pfizer.Vincent P. Zucal, PharmD, is a contractor through Atrium Staffing. He owns Pfizer stock and mutual fund holdings that include other pharmaceutical companies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}